Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 4.06 --0 (-0%)
Previous Close $4.06    52 Week High
Open $4.06    52 Week Low
Day High $4.06    P/E N/A 
Day Low $4.06    EPS
Volume 74,540